{"id":1079,"date":"2021-03-05T13:30:51","date_gmt":"2021-03-05T18:30:51","guid":{"rendered":"https:\/\/research.ncsu.edu\/win\/?p=1079"},"modified":"2023-11-27T15:17:28","modified_gmt":"2023-11-27T20:17:28","slug":"410-medicals-lifeflow-plus-enters-us-market","status":"publish","type":"post","link":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/","title":{"rendered":"410 Medical\u2019s LifeFlow PLUS Enters US Market<\/a>"},"content":{"rendered":"

Durham\u2019s\u00a0410 Medical<\/a>, Inc. has launched sales in the United States of its LifeFlow PLUS Blood and Fluid Infuser, following its U.S. Food and Drug Administration\u00a0clearance in 2020<\/a>.<\/p>\n

The LifeFlow product line delivers fluids to critical patients in a quick and controlled fashion.<\/p>\n

The company\u2019s first LifeFlow product, the LifeFlow Fluid Infuser, supplied general fluids to critical patients with complications like sepsis.<\/p>\n

The new LifeFlow PLUS product can transport crystalloids, blood and blood components in a similarly efficient system, answering a previously unmet need in rapid blood delivery.<\/p>\n

The company says this product will be transformative in treating hemorrhages, or ruptured blood vessels often triggered by a trauma. Hemorrhages are the leading causes of death for people under 46 years old, and a significant number of these deaths occur before the patient enters the hospital. Quick blood delivery has been shown to improve patient outcomes, and LifeFlow PLUS is the first lightweight rapid system to accommodate most IV sizes.<\/p>\n

Its portable nature renders itself uniquely to trauma site usage, in addition to hospital use. Hemorrhagic shock requires immediate fluid resuscitation, which LifeFlow PLUS allows emergency medical technicians to perform onsite. This immediate response can stabilize a crashing patient and help prevent future complications.<\/p>\n

The device,\u00a0manufactured in-state by\u00a0Robling Medical<\/a>\u00a0of Youngsville., is disposable, designed for single-patient use.<\/p>\n

With LifeFlow PLUS on the U.S. market, medical professionals around the country can respond to fatal conditions quickly and efficiently, saving patients\u2019 lives. 410 Medical plans to establish its product as the standard for fluid resuscitation, expanding partnerships with the military, surgical teams and trauma teams.<\/p>\n","protected":false},"excerpt":{"rendered":"

Durham\u2019s\u00a0410 Medical, Inc. has launched sales in the United States of its LifeFlow PLUS Blood and Fluid Infuser, following its U.S. Food and Drug Administration\u00a0clearance in 2020. The LifeFlow product…<\/p>\n","protected":false},"author":1119,"featured_media":1629,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ncst_custom_author":"","ncst_show_custom_author":false,"ncst_dynamicHeaderBlockName":"","ncst_dynamicHeaderData":"","ncst_content_audit_freq":"","ncst_content_audit_date":"","ncst_content_audit_display":false,"ncst_backToTopFlag":"","footnotes":""},"categories":[9],"tags":[140,143,75,144,47],"class_list":["post-1079","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-410-medical","tag-nc-startups","tag-nc-state-university","tag-sepsis","tag-wolfpack-investor-network"],"displayCategory":null,"acf":[],"yoast_head":"\n410 Medical\u2019s LifeFlow PLUS Enters US Market - Wolfpack Investor Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"410 Medical\u2019s LifeFlow PLUS Enters US Market - Wolfpack Investor Network\" \/>\n<meta property=\"og:description\" content=\"Durham\u2019s\u00a0410 Medical, Inc. has launched sales in the United States of its LifeFlow PLUS Blood and Fluid Infuser, following its U.S. Food and Drug Administration\u00a0clearance in 2020. The LifeFlow product…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Wolfpack Investor Network\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-05T18:30:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-27T20:17:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/research.ncsu.edu\/win\/files\/2023\/07\/410Medical.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"200\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/\",\"url\":\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/\",\"name\":\"410 Medical\u2019s LifeFlow PLUS Enters US Market - Wolfpack Investor Network\",\"isPartOf\":{\"@id\":\"https:\/\/research.ncsu.edu\/win\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/research.ncsu.edu\/win\/files\/2023\/07\/410Medical.jpg\",\"datePublished\":\"2021-03-05T18:30:51+00:00\",\"dateModified\":\"2023-11-27T20:17:28+00:00\",\"author\":{\"@id\":\"https:\/\/research.ncsu.edu\/win\/#\/schema\/person\/18101cc838b23e3612dd10637def18cf\"},\"breadcrumb\":{\"@id\":\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#primaryimage\",\"url\":\"https:\/\/research.ncsu.edu\/win\/files\/2023\/07\/410Medical.jpg\",\"contentUrl\":\"https:\/\/research.ncsu.edu\/win\/files\/2023\/07\/410Medical.jpg\",\"width\":200,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/research.ncsu.edu\/win\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"410 Medical\u2019s LifeFlow PLUS Enters US Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/research.ncsu.edu\/win\/#website\",\"url\":\"https:\/\/research.ncsu.edu\/win\/\",\"name\":\"Wolfpack Investor Network\",\"description\":\"Just another Research and Innovation site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/research.ncsu.edu\/win\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/research.ncsu.edu\/win\/#\/schema\/person\/18101cc838b23e3612dd10637def18cf\",\"name\":\"Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/research.ncsu.edu\/win\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/40b915144bbde2e8f65f23e26b341dde?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/40b915144bbde2e8f65f23e26b341dde?s=96&d=mm&r=g\",\"caption\":\"Staff\"},\"url\":\"https:\/\/research.ncsu.edu\/win\/author\/staff\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"410 Medical\u2019s LifeFlow PLUS Enters US Market - Wolfpack Investor Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/","og_locale":"en_US","og_type":"article","og_title":"410 Medical\u2019s LifeFlow PLUS Enters US Market - Wolfpack Investor Network","og_description":"Durham\u2019s\u00a0410 Medical, Inc. has launched sales in the United States of its LifeFlow PLUS Blood and Fluid Infuser, following its U.S. Food and Drug Administration\u00a0clearance in 2020. The LifeFlow product…","og_url":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/","og_site_name":"Wolfpack Investor Network","article_published_time":"2021-03-05T18:30:51+00:00","article_modified_time":"2023-11-27T20:17:28+00:00","og_image":[{"width":200,"height":200,"url":"https:\/\/research.ncsu.edu\/win\/files\/2023\/07\/410Medical.jpg","type":"image\/jpeg"}],"author":"Staff","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Staff","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/","url":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/","name":"410 Medical\u2019s LifeFlow PLUS Enters US Market - Wolfpack Investor Network","isPartOf":{"@id":"https:\/\/research.ncsu.edu\/win\/#website"},"primaryImageOfPage":{"@id":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#primaryimage"},"image":{"@id":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#primaryimage"},"thumbnailUrl":"https:\/\/research.ncsu.edu\/win\/files\/2023\/07\/410Medical.jpg","datePublished":"2021-03-05T18:30:51+00:00","dateModified":"2023-11-27T20:17:28+00:00","author":{"@id":"https:\/\/research.ncsu.edu\/win\/#\/schema\/person\/18101cc838b23e3612dd10637def18cf"},"breadcrumb":{"@id":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#primaryimage","url":"https:\/\/research.ncsu.edu\/win\/files\/2023\/07\/410Medical.jpg","contentUrl":"https:\/\/research.ncsu.edu\/win\/files\/2023\/07\/410Medical.jpg","width":200,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/research.ncsu.edu\/win\/410-medicals-lifeflow-plus-enters-us-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/research.ncsu.edu\/win\/"},{"@type":"ListItem","position":2,"name":"410 Medical\u2019s LifeFlow PLUS Enters US Market"}]},{"@type":"WebSite","@id":"https:\/\/research.ncsu.edu\/win\/#website","url":"https:\/\/research.ncsu.edu\/win\/","name":"Wolfpack Investor Network","description":"Just another Research and Innovation site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/research.ncsu.edu\/win\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/research.ncsu.edu\/win\/#\/schema\/person\/18101cc838b23e3612dd10637def18cf","name":"Staff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/research.ncsu.edu\/win\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/40b915144bbde2e8f65f23e26b341dde?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/40b915144bbde2e8f65f23e26b341dde?s=96&d=mm&r=g","caption":"Staff"},"url":"https:\/\/research.ncsu.edu\/win\/author\/staff\/"}]}},"_links":{"self":[{"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/posts\/1079"}],"collection":[{"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/users\/1119"}],"replies":[{"embeddable":true,"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/comments?post=1079"}],"version-history":[{"count":1,"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/posts\/1079\/revisions"}],"predecessor-version":[{"id":1761,"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/posts\/1079\/revisions\/1761"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/media\/1629"}],"wp:attachment":[{"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/media?parent=1079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/categories?post=1079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/research.ncsu.edu\/win\/wp-json\/wp\/v2\/tags?post=1079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}